King, H., Aubert, R
Compounded GLP-1 medications represent a significant monthly expense
Case presentation SL was a 44 year old Caucasian male with a past medical history of severe morbid obesity (BMI 99), heart failure with preserved ejection fraction, oxygen-dependent obesity hypoventilation syndrome (OHS), chronic non-healing leg wounds, anemia, uncontrolled hypertension on 2 anti-hypertensive agents, limited mobility, and major depressive disorder who presented to an academic medical center for treatment of acute on chronic diastolic heart failure due to progressive dyspnea
Drug Alcohol Depend
[27] Reduced Fat Storage : By enhancing fat oxidation and inhibiting fat storage pathways, GlucoVantage helps direct calories toward energy production rather than fat storage
In: Fox JG, Davisson MT, Quimby FW, Barthold SW, Newcomer CE, Smith AL, editors